報價延遲最少15分鐘:2025/07/03 04:05 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
6.97 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.84/-0.28
|
|
企業價值
174.29M
|
| 資產負債 |
|
每股賬面淨值
0.29
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
55.64M
|
|
每股收益
2.42
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/07/03 04:05 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. |